Safety and efficacy of daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV genotype 3 infection: Interim results of a multicenter European compassionate use program - Welzel, T M; Petersen, J; Ferenci, P (Hepatology, 2015)
et al.